The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis-Reference-Cited by-同舟云学术

The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis

Published:2007 Issue:3 Volume:56 Page:965-971
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Bleesing Jack,Prada Anne,Siegel David M.,Villanueva Joyce,Olson Judyann,Ilowite Norman T.,Brunner Hermine I.,Griffin Thomas,Graham Thomas B.,Sherry David D.,Passo Murray H.,Ramanan Athimalaipet V.,Filipovich Alexandra,Grom Alexei A.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference15 articles.

1. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: Possible relationship to drugs or infection

2. Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?

3. Defective Natural Killer Cell Function in Patients with Hemophagocytic Lymphohistiocytosis and in First Degree Relatives

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of biomarkers for COVID-19 associated secondary hemophagocytic lymphohistiocytosis;2024-08-15

2. Unleashing the Cytokine Storm: A Case of Macrophage Activation Syndrome in Systemic Lupus Erythematosus;Cureus;2024-06-25

3. Macrophage Activation Syndrome in Children: Update on Diagnosis and Treatment;Children;2024-06-21

4. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease;Journal of Autoimmunity;2024-04

5. Identification of miRNAs that target Fcγ receptor-mediated phagocytosis during macrophage activation syndrome;Frontiers in Immunology;2024-03-15